Wall Street analysts forecast that Vertex Pharmaceuticals (VRTX) will report quarterly earnings of $4.24 per share in its upcoming release, pointing to a year-over-year increase of 133.1$2.89 billion, exhibiting an increase of 9.2% compared to the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates dur ...